424B3

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Mar 3, 2021
Document Date
Mar 3, 2021
Form Description
Form of prospectus reflecting facts events constituting substantive change from last form
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC